Interpace Biosciences Market Cap

Interpace Biosciences has a market cap or net worth of $4.73 million as of December 5, 2025. Its market cap has decreased by -64.17% in one year.

Market Cap

4.73M

Enterprise Value

5.56M

Revenue

41.92M

Ranking

n/a

PE Ratio

9.84

Stock Price

$1.07

Market Cap Chart

Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 4.73M, a decrease of -97.87%. That is a compound annual growth rate of -13.03%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	4.73M	-60.18%
Dec 31, 2024	11.87M	152.98%
Dec 29, 2023	4.69M	5.76%
Dec 30, 2022	4.44M	-85.77%
Dec 31, 2021	31.18M	145.72%
Dec 31, 2020	12.69M	-33.55%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	815.80M
Elite Pharmaceuticals	558.58M
Glass House Brands	531.36M
CytoDyn	416.55M
American Oncology Network	367.13M
Northwest Biotherapeutics	364.92M
Silence Therapeutics	336.78M
Nika Pharmaceuticals	259.91M

Market Cap Rankings